What is the main difference between AOD-9604 and CT-388?

Both AOD-9604 and CT-388 are categorized under Metabolic, but they differ in evidence strength. AOD-9604 has Low evidence (20 sources), while CT-388 has Moderate evidence (8 sources).

Which has more clinical evidence, AOD-9604 or CT-388?

Both have similar numbers of human studies (6 each). AOD-9604 has Low evidence strength and CT-388 has Moderate.

Are AOD-9604 and CT-388 FDA approved?

AOD-9604 has Low clinical evidence and is not FDA-approved for general use. CT-388 has moderate clinical evidence from human studies, though its regulatory status varies. Always verify current regulatory status with official sources.

Can AOD-9604 and CT-388 be combined?

There is no published research on combining AOD-9604 and CT-388. The safety and efficacy of any combination is unknown without clinical data.

Metabolic Comparison

AOD-9604 vs CT-388

Comparison of AOD-9604 (Low evidence) and CT-388 (Moderate evidence).

Last updated: February 12, 2026

AOD-9604

Low Evidence

View full dossier

CT-388

Moderate Evidence

View full dossier

Overview

AOD-9604 and CT-388 are both studied in the peptide research space.

AOD-9604: A modified fragment of human growth hormone (amino acids 176-191 with N-terminal tyrosine) studied for fat loss.

CT-388: A dual GLP-1/GIP receptor agonist acquired by Roche through the $2.

Evidence Comparison

Aspect	AOD-9604	CT-388
Evidence Level	Low	Moderate
Human Studies	6	6
Preclinical Studies	8	2
Total Sources	20	8

Key Differences

Aspect	AOD-9604	CT-388
Category	Metabolic	Metabolic
Evidence Strength	Low	Moderate
Total Sources	20	8
Human Studies	6	6

Summary

AOD-9604: Low evidence with 20 total sources (6 human)
CT-388: Moderate evidence with 8 total sources (6 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

View Full Dossiers

AOD-9604 Evidence Dossier CT-388 Evidence Dossier

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.